Search

Ruby Prosser Scully wrote a nice phage therapy article for the Australian healthcare professional-targeted paper Medical Republic. She interviews Australian phage researchers Peter Speck, Jon Iredell and Jeremy Barr, among others who are wo

The next rendition of PHAVES will be a seminar with Rodrigo Ibarra Chavez on Oct 20 at 11AM Eastern / 5PM CEST. He'll tell us about phage-inducible chromosomal islands (PICIs), piracy in the phage-world, and insights on their application in

This week, we're highlighting the four feature articles we published in September: two guest blog posts, an interview, and a recap of the two PHAVES events we hosted this month. Enjoy! In place of a feature article this week, we're highligh

The Bullough lab at the University of Sheffield, UK will soon hire a PhD student to study phage infection of C. difficile with cryoEM.

The Niu lab at the University of Calgary Faculty of Veterinary Medicine has an opening for a postdoc to study phage-host interactions, phage functional genomics, and viral metagenomics.

15 PhD positions are open as part of the virology and bioinformatics "ETN VIROINF" program, a Horizon 2020-funded program involving institutes in 8 countries. Several project openings are phage-related!

The Turner lab at Yale University is looking to hire a postdoc to study phage evolution or virus biodiversity.

Thanks so much to the nearly 300 people who attended the first iVoM webinar! The second iVoM event will be Thursday, October 15, 4PM GMT, and the theme will be "Virus structures and function". It will feature talks by: Petr Leiman, Univers

Thanks so much to the nearly 300 people who attended the first iVoM webinar! The second iVoM event will be Thursday, October 15, 4PM GMT, and the theme will be "Virus structures and function". It will feature talks by: Petr Leiman, Univers

Emily’s Entourage, a nonprofit organization that funds cystic fibrosis research and drug development, has funded four new grants (totaling $790,000 over two years), two of which are phage-related. One was awarded to IPATH researchers to dev

Locus Biosciences signed a $144 million contract with BARDA to support phase II and III clinical trials of LBP-EC01, Locus' CRISPR phage (crPhage™) product.

Adaptive Phage Therapeutics was recognized as a 2020 Champion of Maryland Manufacturing for its efforts to provide emergency phage access to COVID-19 patients with secondary bacterial infections.

Laith Harb (Texas A&M University) and colleagues published a new paper in PNAS showing that host cell penetration by the F-pilus-specific ssRNA phage MS2 triggers detachment of the F-pilus.

Luís Melo (University of Minho, Portugal) and colleagues published a detailed analysis of how the Staphylococcus epidermidis biofilm matrix protects against phage predation.

Xing Wan (KU Leuven and University of Helsinki) and colleagues published a new review in Current Opinion in Biotechnology on phage-based target discovery and its exploitation towards novel antibacterial molecules.

This month, we hosted two episodes of PHAVES! Here's your recap of both, along with links to the recordings. Thanks very much to our special guests, Dr. Sabrina Green and Dr. Panos Kalatzis. This month, we hosted two PHAVES events; here's y

Lund University (Lund, Sweden) is hiring a researcher to be responsible for research tasks dealing with development of biocatalysts for designing effective antimicrobial strategies. Phage knowledge required.

The Indian ‘Society for Bacteriophage Research and Therapy’ (SBRT) is a platform for phage researchers to share their expertise & resources. SBRT is pleased to announce a webinar on “Knowing the unknown: Approaches to characterize the vast

The next rendition of PHAVES will be a seminar/Q&A with Dr. Emma Bell, Principal Bacteriophage Scientist at FixedPhage, and will take place October 6th at 4PM GMT+1. She'll discuss their phage immobilization technology and how they've impro

Viperins are known to function in the eukaryotic antiviral response, and now they've been found in prokaryotes. Aude Bernheim (Weizmann Institute of Science) and colleagues published a new paper in Nature on prokaryotic viperins, which prot